Loading...
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
BACKGROUND: Neuroinflammation plays a pathogenic role in Parkinson's disease (PD). Immunotherapies that restore brain homeostasis can mitigate neurodegeneration by transforming T cell phenotypes. Sargramostim has gained considerable attention as an immune transformer through laboratory bench to...
Na minha lista:
| Udgivet i: | EBioMedicine |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138485/ https://ncbi.nlm.nih.gov/pubmed/34000620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2021.103380 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|